loader
Please Wait
Applying Filters...

List of Drug Master Files (DMF) of MolPort-002-042-265 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1SCI Pharmtech

02 1Catalytica

03 1Zambon Switzerland

04 2Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 17355

Submission : 2004-04-26

Status : Active

Type : II

SCI Company Banner

02

Boulder Peptide 2024
Not Confirmed

03

Boulder Peptide 2024
Not Confirmed

04

Hoechst Marion Roussel Inc

Country

USDMF

arrow
Boulder Peptide 2024
Not Confirmed

04

Hoechst Marion Roussel Inc

Country
arrow
Boulder Peptide 2024
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 2167

Submission : 1973-10-17

Status : Inactive

Type : II

blank

05

Sumika Fine Chemicals Co Ltd

Country

USDMF

arrow
Boulder Peptide 2024
Not Confirmed

05

Sumika Fine Chemicals Co Ltd

Country
arrow
Boulder Peptide 2024
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 7761

Submission : 1988-11-22

Status : Inactive

Type : II

blank

MolPort-002-042-265 Manufacturers | Traders | Suppliers

MolPort-002-042-265 Manufacturers, Traders, Suppliers 1
60

We have 3 companies offering MolPort-002-042-265

Get in contact with the supplier of your choice:

  1. SCI Pharmtech
  2. Catalytica
  3. Zambon Switzerland